Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127313201 | 12731320 | 1 | I | 20160830 | 0 | 20160908 | 20160908 | DIR | FDA-CTU | 37.00 | YR | F | N | 250.00000 | LBS | 20160908 | N | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127313201 | 12731320 | 1 | PS | PIPERACILLIN/TAZOBACTAM 40.5GM VIAL | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | 6019TW | 20190331 | 0 | 4.5 | G | Q8H | ||||||
| 127313201 | 12731320 | 3 | C | ABILIFY | ARIPIPRAZOLE | 1 | 0 | ||||||||||||
| 127313201 | 12731320 | 5 | C | DIPYRIDAMOLE. | DIPYRIDAMOLE | 1 | 0 | ||||||||||||
| 127313201 | 12731320 | 7 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | 0 | ||||||||||||
| 127313201 | 12731320 | 9 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 | ||||||||||||
| 127313201 | 12731320 | 11 | C | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | 0 | ||||||||||||
| 127313201 | 12731320 | 13 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | 0 | ||||||||||||
| 127313201 | 12731320 | 15 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127313201 | 12731320 | 17 | C | WARFARIN | WARFARIN | 1 | 0 | ||||||||||||
| 127313201 | 12731320 | 19 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 127313201 | 12731320 | 21 | C | DULOXETINE. | DULOXETINE | 1 | 0 | ||||||||||||
| 127313201 | 12731320 | 23 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 127313201 | 12731320 | 25 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 | ||||||||||||
| 127313201 | 12731320 | 26 | SS | METOPROLOL. | METOPROLOL | 1 | 0 | ||||||||||||
| 127313201 | 12731320 | 28 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127313201 | 12731320 | 1 | Infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127313201 | 12731320 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127313201 | 12731320 | Diarrhoea | |
| 127313201 | 12731320 | Hypersensitivity | |
| 127313201 | 12731320 | Nausea | |
| 127313201 | 12731320 | Pyrexia | |
| 127313201 | 12731320 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 127313201 | 12731320 | HP |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127313201 | 12731320 | 1 | 20160803 | 20160830 | 0 |